| Name | Title | Contact Details |
|---|
BKD CPAs & Advisors is a top-tier CPA and advisory firm dedicated to helping people and businesses realize their goals. Our approximately 2,900 dedicated professionals offer solutions to clients in all 50 states and internationally. Our expertise goes well beyond the standard accounting services to include risk management, technology, wealth management and forensic and valuation services. Our clients represent a wide range of industries, and were even part of an alliance of firms that gives us a global reach.
Forever North Partners (FNP) is a purpose-driven company partnering with high-achieving businesses poised for the next phase of growth. Focused on companies possessing unique, disruptive technologies or services, FNP is dedicated to facilitating your ascent to new heights. FNP services offerings: Investees and Investors: FNP excels in collaborating with dynamic, forward-thinking companies seeking additional investment capital to fuel their growth ambitions. Leveraging its extensive network, FNP identifies investors whose interests align with your companies potential. Operational Excellence Services: Boasting over a century of collective industry experience, FNP applies its proven Market-Driven Application Approach to craft precise positioning and messaging strategies empowering your company to penetrate competitive markets, secure new customers, and drive sales. FNP crafts targeted sales and marketing campaigns complete with compelling collateral, ensuring effective outreach to high-value customers within specific application spaces. FNPs network of key opinion leaders (KOLs) will amplify your corporate messaging to drive top-line growth. Executive Recruiting: FNP understands that success hinges on having the right people in pivotal roles. While adopting the necessary tools for growth is crucial, it is the people who epitomize your values and culture that truly propel your company forward. Leadership, especially, demands exceptional individuals who embody your vision and are committed to realizing your companys mission. FNP has earned a stellar reputation for identifying and securing high-caliber, high-performance executives capable of translating your vision into reality. Regulatory Affairs: Navigating the intricate landscape of the life sciences market demands a profound understanding of ever-changing regulatory compliance issues. Reach regulatory excellence with FNP - Your Trusted Life Sciences Partner. Let FNP guide you on your journey to success.
As a leading franchise brokerage firm in the USA and Canada, Klimate Group is renowned for its exceptional reputation in the industry. Specializing in connecting aspiring entrepreneurs with top franchise opportunities, Klimate Group stands out for its extensive network of franchisors, personalized guidance for franchisees, and commitment to fostering successful partnerships. With a track record of matching individuals with franchises that align with their goals and values, Klimate Group has established itself as a trusted and innovative player in the franchising world, setting the standard for excellence and professionalism.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Acrisure Re is a leading re/insurance intermediary and corporate advisor/broker dealer, offering bespoke and innovative capital, risk, and program solutions. Our expert multi-disciplinary team leverage their combined experience, market data and leading analytics to provide the very best placement and execution strategies. Operating in Bermuda, Florida, Italy, London, Minnesota, New York, North Carolina, Seattle, Toronto and Zurich, our global team of experienced and talented employees are dedicated to driving a sophisticated, tech-enabled future for the (re)insurance industry.